Abbott announces its intention to separate its global Nutrition business into an independent, publicly traded company
Abbott introduces Ensure® Max Protein 3-in-1 Muscle Support, bringing the benefits of a supplement stack into one scoop
Abbott launches SimpleScreen CRC blood test, joining Cologuard Plus® in its colorectal cancer screening portfolio
First Canadian Commercial Use of Abbott's Volt Pulsed Field Ablation System Advances Minimally Invasive Atrial Fibrillation Care
Abbott receives FDA approval for its TactiFlex Duo Ablation Catheter to treat people with abnormal heart rhythms
Abbott launches the first and only ready-to-feed liquid infant formula made with whole milk in the U.S. at similar price to its existing Similac powdered formula
Abbott's next-generation Amulet 360 device receives CE Mark to treat people with atrial fibrillation at risk of stroke
Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetes
Abbott reaches agreements to resolve a portion of litigation involving its specialty formulas for preterm infants
Abbott and NACHC launch nationwide Food for Health initiative to make nutritious food a core part of healthcare
ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease Testing
Brixton Metals Announces Closing of Option Agreement to Acquire a 100% Interest in the Silver Focused Silvergruvan Project in Sweden
Spartan Metals Expands Victorio Tungsten-Molybdenum Resource with Measured and Indicated Grades of 0.25% MoEq or 0.15% WO3Eq
